BioPharmGuy logo
Sponsored By:
Project Management Now
Purchase the BioPharmGuy data
Trianni
Stemcentrx is defunct.

Fate: Bought by AbbVie, April 2016, $5.8B +$4B milestones


------------------
If you believe any of this information is incorrect, please let us know.